Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07457697

MyGENESIS-PATH: Digital Program for Donor-Conceived People

MyGENESIS-PATH is a self-guided digital psychoeducational intervention designed to support donor-conceived adults in navigating donor-conception-related information and uncertainty, DNA testing, identity, family relationships, disclosure, stigma, and expectations concerning donors and donor siblings.

This two-arm randomized pilot and feasibility trial will evaluate the feasibility and acceptability of delivering MyGENESIS-PATH and of conducting a future definitive randomized controlled trial. Sixty donor-conceived adults will be randomly allocated in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control condition.

Primary feasibility outcomes will assess recruitment, completion of the 4-week follow-up assessment, completeness of psychosocial outcome data, intervention uptake and completion, and completion of the immediate post-intervention feedback assessment. Intervention acceptability, usability, perceived usefulness, relevance, emotional manageability, and potential unwanted effects will be assessed among participants allocated to MyGENESIS-PATH.

Changes in perceived stress, psychological well-being, coping, and donor-conception-related identity from baseline to 4 weeks after randomization will be examined as exploratory outcomes. The study is not powered to detect definitive intervention effects.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Psychosocial Stress Behavior Personal Satisfaction Psychological Well-Being

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Psychology and Education Sciences, University of Porto

Porto, Porto District, 4200, Portugal

Location contact

Research management officer, PhD

CONTACT

[email protected]

226079700 ext. 388

About this study

MyGENESIS-PATH is a structured, self-guided digital psychoeducational intervention developed as part of the MyGENESIS project. Its development was informed by existing evidence, psychological theory, qualitative and quantitative research with donor-conceived people, and consultation with people with lived experience and relevant professional expertise.

Before the randomized trial, a separate alpha-testing phase will be conducted with donor-conceived adults and expert reviewers to identify major problems relating to comprehensibility, relevance, emotional safety, usability, and technical functioning. Participants involved in alpha testing will not be eligible for the randomized pilot trial.

The registered study is a two-arm, parallel-group randomized pilot and feasibility trial involving 60 donor-conceived adults. After providing informed consent and completing the baseline questionnaire, participants will be randomized automatically within LimeSurvey in a 1:1 ratio to immediate access to MyGENESIS-PATH or to a waitlist control condition.

Participants allocated to the intervention group will receive access to MyGENESIS-PATH. The intervention comprises six psychoeducational modules, reflective activities, brief self-assessment check-ins, tailored pathways, and conditional coping exercises. Its content addresses:

donor-conception-related information and legal contexts; DNA testing and associated decisions and experiences; donor conception and identity; expectations concerning donors and donor siblings; family relationships, disclosure, support, and stigma; and integration, coping, psychological well-being, and support resources.

Brief check-ins embedded within the intervention are used to tailor coping content to participants' current experiences. Depending on participants' responses, they may receive no additional coping content, a moderate-support exercise, or an elevated-support exercise. Only one level of support is presented for each assessed domain.

Participants will be encouraged to complete the intervention within the access period. Immediately after reaching the end of the intervention, they will be invited to complete a brief feedback questionnaire assessing acceptability, usability, usefulness, relevance, emotional manageability, technical problems, and potential unwanted effects.

Participants allocated to the waitlist control group will not receive access to MyGENESIS-PATH during the initial study period. Both groups will complete psychosocial outcome assessments at baseline and 4 weeks after randomization. Waitlist participants will be offered access to MyGENESIS-PATH after completing the 4-week follow-up assessment.

The study will primarily assess the feasibility and acceptability of recruitment, randomization, intervention delivery and use, immediate feedback collection, participant follow-up, and psychosocial outcome-data collection. Psychological outcomes will be examined descriptively and exploratorily to assess their suitability, variability, and potential responsiveness for a future definitive trial.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Donor-conceived people
  • Aged 18 or over
  • Able to read and understand English
  • Provide informed consent

Exclusion criteria

  • Previous participation in the MyGENESIS-PATH alpha-testing phase
  • Unable to provide informed consent
  • Unable to complete the online study procedures

Treatment and study plan

MyGENESIS Digital Psychoeducational Program

Behavioral

A self-guided digital psychoeducational intervention based on cognitive-behavioral principles and the transactional model of stress.

Primary outcomes

  1. Recruitment feasibility

    Time frame: From recruitment opening to completion of recruitment, anticipated to be approximately 3 months

    Number of eligible participants who provide informed consent, complete the baseline questionnaire, and are randomized during the planned recruitment period. The recruitment target is 60 randomized participants within the planned recruitment period. The number screened, number eligible, number consenting, number completing baseline, and mean number randomized per month will also be reported.

  2. Acceptability of MyGENESIS-PATH

    Time frame: Immediately after completing the intervention.

    Acceptability will be assessed immediately after intervention completion among participants allocated to MyGENESIS-PATH using participant ratings of perceived usefulness; perceived relevance; emotional manageability; willingness to recommend the intervention to another donor-conceived person.

    Acceptability will also be explored qualitatively through optional open-ended feedback.

  3. Completion of the 4-week follow-up assessment

    Time frame: 4 weeks after randomization

    Percentage of all randomized participants who submit the 4-week follow-up questionnaire. The numerator will be the number of randomized participants submitting the follow-up questionnaire, and the denominator will be all randomized participants. A completion rate of at least 80% will support progression without major modification.

Secondary outcomes

  1. Psychological well-being

    Time frame: Baseline (pre-intervention) and 4 weeks post-randomization

    Change in the WHO well-being index (WHO-5) total score (range 0-40, higher scores indicating greater well-being )

  2. Coping

    Time frame: Baseline (pre-intervention) and 4 weeks post-randomization

    Change in coping responses as measured by the Brief COPE Inventory subscale scores (14 subscales, each ranging from 2-8, with higher scores indicating greater use of the respective coping strategy)

  3. Donor-conception identity

    Time frame: Baseline (pre-intervention) and 4 weeks post-randomization

    Change in donor conception identity as measured by the Donor Conception Identity Questionnaire (DCIQ) subscale scores, including Concern and Preoccupation (range 8-40), Internalized Stigma (range 5-25), Pride and Acceptance (range 6-30), and Openness and Understanding (range 4-20)

    Higher scores indicate greater endorsement of the respective donor conception identity domain.

Study contacts

Contact information is provided by the study sponsor or research team.

Maria E. Costa, PhD

CONTACT

[email protected]

+351 220 400 667

Mariana V. Martins, PhD

CONTACT

[email protected]

+351 220 400 667

Sponsors and collaborators

Lead sponsor

Universidade do Porto

Other

Collaborators

  • Fundação para a Ciência e a Tecnologia

Registry information

Official study title

A Randomized Pilot and Feasibility Trial of a Digital Psychoeducational Intervention for Donor-Conceived Adults (MyGENESIS-PATH)

Acronym: MyGENESIS-Path

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Mar 9, 2026
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.